Investseekers cites Israeli TV reports that Novo Nordisk is preparing to bring the Wegovy pill to Israel within days.
Recap by typeshit. Post by Investseekers on X.
BMO's Evan Seigerman expects US share losses to weigh on Ozempic sales, while the 25% CagriSema figure comes from a post-hoc subgroup, not the full trial's 22.7%.
Beauty companies are reportedly exploring products aimed at facial changes linked to rapid weight loss on GLP-1 drugs.
A search page for retatrutide news with no specific story attached, so there is little new beyond recent coverage.
2:06:48
A live Q&A stream from DOWNSIZED taking viewer questions about GLP-1 medications, including Zepbound, Wegovy and Foundayo.
Talker Research polled 2,000 Americans for aesthetics company Revance. Of 1,402 GLP-1 users, over 24% reported a new identity shift after starting the drugs.
Tirzepatide is the first dual GIP and GLP-1 drug cleared to cut major cardiovascular events, backed by the head-to-head SURPASS-CVOT trial.
Loading…